发布求助
文献互助 智能选刊 最新文献

P and T最新文献

筛选
英文 中文
Democratic Takeover of House Sparks Drug-Price Legislation Talks: But Strong Legislation Unlikely Given Patient and Industry Opposition. 民主党接管众议院引发药品价格立法谈判:但由于患者和行业的反对，强有力的立法不太可能。
P and T Pub Date : 2019-04-01
Stephen Barlas
{"title":"Democratic Takeover of House Sparks Drug-Price Legislation Talks: But Strong Legislation Unlikely Given Patient and Industry Opposition.","authors":"Stephen Barlas","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>HHS has proposed regulations to attack high drug prices, a priority for the current administration. Both parties have spoken out against the drug companies but the change in control of the House is no guarantee of pricing legislation moving forward. And if drug manufacturers, PBMs, and others are adamant about tackling drug prices, why do they oppose the best cost-cutting proposals?</p>","PeriodicalId":38773,"journal":{"name":"P and T","volume":"44 4","pages":"180-200"},"PeriodicalIF":0.0,"publicationDate":"2019-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428499/pdf/ptj4404180.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37105233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research Briefs. 研究简报。
P and T Pub Date : 2019-04-01
{"title":"Research Briefs.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":38773,"journal":{"name":"P and T","volume":"44 4","pages":"212-215"},"PeriodicalIF":0.0,"publicationDate":"2019-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428494/pdf/ptj4404212.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37105237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
"Use as Directed" Can Cause Confusion for Both Patients and Practitioners. “按指示使用”可能会引起患者和医生的混淆。
P and T Pub Date : 2019-04-01
Matthew Grissinger
{"title":"\"Use as Directed\" Can Cause Confusion for Both Patients and Practitioners.","authors":"Matthew Grissinger","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The familiar but ambiguous <i>sigs</i> on prescriptions are often of limited help to patients and pharmacists. Sometimes, the instruction to \"use as directed\" has resulted in serious errors.</p>","PeriodicalId":38773,"journal":{"name":"P and T","volume":"44 4","pages":"168-169"},"PeriodicalIF":0.0,"publicationDate":"2019-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428496/pdf/ptj4404168.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37106219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trump Administration Announces Long-Awaited Rebate Changes: One Safe Harbor Eliminated, Two Others Created. 特朗普政府宣布期待已久的退税改革:取消一个安全港，新增两个。
P and T Pub Date : 2019-04-01
Stephen Barlas
{"title":"Trump Administration Announces Long-Awaited Rebate Changes: One Safe Harbor Eliminated, Two Others Created.","authors":"Stephen Barlas","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The current rebate \"safe harbor\" encourages drug manufacturers to inflate list prices. The HHS's newly proposed rule threatens to eliminate this safe harbor but offers two new ones instead.</p>","PeriodicalId":38773,"journal":{"name":"P and T","volume":"44 4","pages":"167"},"PeriodicalIF":0.0,"publicationDate":"2019-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428500/pdf/ptj4404167.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37106218","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
American Society of Clinical Oncology Genitourinary Symposium and Integrative Healthcare Symposium. 美国临床肿瘤学会泌尿生殖系统研讨会和综合保健研讨会。
P and T Pub Date : 2019-04-01
Walter Alexander
{"title":"American Society of Clinical Oncology Genitourinary Symposium and Integrative Healthcare Symposium.","authors":"Walter Alexander","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>From ASCO, we report on metastatic castrate-resistant prostate cancer and locally advanced/metastatic renal cell carcinoma. From IHS, we report on complementary and alternative medicine use by patients and practitioners, the effects of biological hemp-derived cannabidiol on PTSD in military veterans, and more.</p>","PeriodicalId":38773,"journal":{"name":"P and T","volume":"44 4","pages":"204-209"},"PeriodicalIF":0.0,"publicationDate":"2019-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428497/pdf/ptj4404204.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37105236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of a Comprehensive COPD Therapeutic Interchange Program on 30-Day Readmission Rates in Hospitalized Patients. 综合COPD治疗交换方案对住院患者30天再入院率的影响
P and T Pub Date : 2019-04-01
Maren A McGurran, Lisa M Richter, Nathan D Leedahl, David D Leedahl
{"title":"Impact of a Comprehensive COPD Therapeutic Interchange Program on 30-Day Readmission Rates in Hospitalized Patients.","authors":"Maren A McGurran,&nbsp;Lisa M Richter,&nbsp;Nathan D Leedahl,&nbsp;David D Leedahl","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Purpose: </strong>Chronic obstructive pulmonary disease (COPD) is the third leading cause of death in the United States. The economic effect of COPD management is substantial, and the prevalence of the disease continues to rise with the growth of older populations. The purpose of this study was to evaluate the clinical and financial impact of a comprehensive therapeutic interchange program (CTIP) in hospitalized patients with COPD. The primary outcome was a 30-day readmission rate, with the following secondary outcomes: 30-day mortality and pharmacy-inhaled medication cost per patient.</p><p><strong>Methods: </strong>This study was a multi-center, retrospective, electronic chart review of patients with a diagnosis of COPD admitted to two hospitals from July 1, 2016 to June 30, 2017. Our intervention group was admitted to a 550-bed tertiary care hospital and was managed with a pharmacist-led CTIP for inhaled products used in COPD. Our control group was admitted to a 545-bed tertiary care hospital, which did not have a CTIP in place.</p><p><strong>Results: </strong>2,885 hospitalized patients with a diagnosis of COPD were included in the analysis (1,350 in the intervention group and 1,535 in the control group). Univariable analysis demonstrated that the intervention group was associated with a lower 30-day readmission rate (5.8% vs. 8.3%; <i>P</i> = 0.012) and a lower average pharmacy-inhaled medication cost ($221 vs. $311; <i>P</i> = < 0.01). There was no statistical difference in 30-day mortality.</p><p><strong>Conclusion: </strong>This study demonstrates that the use of a pharmacist-led CTIP of COPD inhalers does not worsen patient outcomes and may provide pharmacy cost savings. The cohort managed with a CTIP was statistically associated with a lower 30-day readmission rate and lower pharmacy-inhaled medication costs without any difference in 30-day mortality.</p>","PeriodicalId":38773,"journal":{"name":"P and T","volume":"44 4","pages":"185-191"},"PeriodicalIF":0.0,"publicationDate":"2019-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428498/pdf/ptj4404185.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37105234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Guide to Bacterial Culture Identification And Results Interpretation. 细菌培养鉴定和结果解释指南。
P and T Pub Date : 2019-04-01
Christopher Giuliano, Chandni R Patel, Pramodini B Kale-Pradhan
{"title":"A Guide to Bacterial Culture Identification And Results Interpretation.","authors":"Christopher Giuliano,&nbsp;Chandni R Patel,&nbsp;Pramodini B Kale-Pradhan","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Purpose: </strong>To provide a guide to interpreting bacterial culture results.</p><p><strong>Methods: </strong>Studies were identified via a PubMed literature search (from 1966 to January 2018). Search terms included microbial sensitivity tests, microbial drug resistance, and anti-infective agents/pharmacology. Articles were included if they were published in English. References within identified articles were also reviewed.</p><p><strong>Results: </strong>This paper reviewed core concepts of interpreting bacterial culture results, including timing of cultures, common culture sites, potential for contamination, interpreting the Gram stain, role of rapid diagnostic tests, conventional antibiotic susceptibility testing, and automated testing.</p><p><strong>Conclusion: </strong>This guide can assist pharmacists in their role as integral members of the antimicrobial stewardship team in an effort to improve patient care.</p>","PeriodicalId":38773,"journal":{"name":"P and T","volume":"44 4","pages":"192-200"},"PeriodicalIF":0.0,"publicationDate":"2019-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428495/pdf/ptj4404192.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37105235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Drug and Device News. 药品和器械新闻。
P and T Pub Date : 2019-04-01
{"title":"Drug and Device News.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Approvals, new indications and formulations, and safety issues.</p>","PeriodicalId":38773,"journal":{"name":"P and T","volume":"44 4","pages":"170-202"},"PeriodicalIF":0.0,"publicationDate":"2019-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428501/pdf/ptj4404170.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37106220","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmaceutical Approval Update. 药品审批更新。
P and T Pub Date : 2019-04-01
Michele B Kaufman
{"title":"Pharmaceutical Approval Update.","authors":"Michele B Kaufman","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Motegrity (prucalopride) for chronic idiopathic constipation; Aemcolo (rifamycin) for travelers' diarrhea; and Dextenza (dexamethasone ophthalmic insert) for ocular pain after ophthalmic surgery.</p>","PeriodicalId":38773,"journal":{"name":"P and T","volume":"44 4","pages":"178-209"},"PeriodicalIF":0.0,"publicationDate":"2019-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428493/pdf/ptj4404178.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37106221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Meropenem-Vaborbactam (Vabomere™): Another Option for Carbapenem-Resistant Enterobacteriaceae. meropenene - vaborbactam (Vabomere™):碳青霉烯耐药肠杆菌科的另一种选择。
P and T Pub Date : 2019-03-01
Yuman Lee, Juliette Kim, Saralinh Trinh
{"title":"Meropenem-Vaborbactam (Vabomere<sup>™</sup>): Another Option for Carbapenem-Resistant Enterobacteriaceae.","authors":"Yuman Lee,&nbsp;Juliette Kim,&nbsp;Saralinh Trinh","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Meropenem-Vaborbactam (Vabomere) for carbapenem-resistant Enterobacteriaceae.</p>","PeriodicalId":38773,"journal":{"name":"P and T","volume":"44 3","pages":"110-113"},"PeriodicalIF":0.0,"publicationDate":"2019-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385729/pdf/ptj4403110.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37193745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信